Previous Close | 23.60 |
Open | 23.41 |
Bid | 23.69 x 0 |
Ask | 23.70 x 0 |
Day's Range | 23.41 - 24.30 |
52 Week Range | 16.49 - 27.90 |
Volume | |
Avg. Volume | 39,225,984 |
Market Cap | 154.233B |
Beta (5Y Monthly) | 0.42 |
PE Ratio (TTM) | 10.39 |
EPS (TTM) | 2.28 |
Earnings Date | Mar 28, 2024 |
Forward Dividend & Yield | 3.07 (13.01%) |
Ex-Dividend Date | Jul 17, 2023 |
1y Target Est | 20.98 |
Subscribe to Yahoo Finance Plus to view Fair Value for 600188.SS
GSK is expected to guide for at least low single-digit EPS growth for 2024 and settle the Zantac litigation case within the coming months, Jefferies said, raising its rating on the stock to buy from hold and lifting its target price to 1,900 pence from 1,550 pence.